![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
LM Kamendulis, MR Brzezinski, EV Pindel, WF Bosron and RA Dean
Department of Pathology, Indiana University School of Medicine, Indianapolis, USA.
Concomitant i.v. use of cocaine and heroin ("speedballing") is prevalent among drug-abusing populations. Heroin is rapidly metabolized by sequential deacetylation of two separate ester bonds to yield 6- monoacetylmorphine and morphine. Hydrolysis of heroin to 6- monoacetylmorphine is catalyzed by pseudocholinesterase. The pathway for hydrolysis of 6-monoacetylmorphine to morphine in vivo has yet to be established. Pseudocholinesterase and two human liver carboxylesterases [human liver carboxylesterase form 1 (hCE-1) and human liver carboxylesterase form 2 (hCE-2)] catalyze the rapid hydrolysis of ester linkages in cocaine. This investigation examined the relative catalytic efficiencies of hCE-1, hCE-2 and pseudocholinesterase for heroin metabolism and compared them with cocaine hydrolysis. Enzymatic formation of 6-monoacetylmorphine and morphine was determined by reverse-phase high-performance liquid chromatography. All three enzymes rapidly catalyzed hydrolysis of heroin to 6-monoacetylmorphine (hCE-1 kcat = 439 min-1, hCE-2 kcat = 2186 min-1 and pseudocholinesterase kcat = 13 min-1). The catalytic efficiency, under first-order conditions, for hCE-2-catalyzed formation of 6-monoacetylmorphine (314 min-1 mM-1) was much greater than that for either hCE-1 or pseudocholinesterase (69 and 4 min-1 mM-1, respectively). Similarly, the catalytic efficiency for hydrolysis of 6- monoacetylmorphine to morphine by hCE-2 (22 min-1 mM-1) was substantially greater than that for hCE-1 (0.024 min-1 mM-1). Cocaine competitively inhibited hCE-1-, hCE-2- and pseudocholinesterase- catalyzed hydrolysis of heroin to 6-monoacetylmorphine (Ki = 530, 460 and 130 microM, respectively) and 6-monoacetylmorphine hydrolysis to morphine (Ki = 710, 220 and 830 microM, respectively). These data demonstrate that metabolism of cocaine and heroin in humans is mediated by common metabolic pathways. The role of hepatic hCE-2 is particularly important for the hydrolysis of heroin to 6-monoacetylmorphine and of 6- monoacetylmorphine to morphine.
This article has been cited by other articles:
|
|
 |
|
  E. T. Williams, K. O. Jones, G. D. Ponsler, S. M. Lowery, E. J. Perkins, S. A. Wrighton, K. J. Ruterbories, M. Kazui, and N. A. Farid The Biotransformation of Prasugrel, a New Thienopyridine Prodrug, by the Human Carboxylesterases 1 and 2 Drug Metab. Dispos., July 1, 2008; 36(7): 1227 - 1232. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Alam, D. Gilham, D. E. Vance, and R. Lehner Mutation of F417 but not of L418 or L420 in the lipid binding domain decreases the activity of triacylglycerol hydrolase J. Lipid Res., February 1, 2006; 47(2): 375 - 383. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. P. Landowski, P. L. Lorenzi, X. Song, and G. L. Amidon Nucleoside Ester Prodrug Substrate Specificity of Liver Carboxylesterase J. Pharmacol. Exp. Ther., February 1, 2006; 316(2): 572 - 580. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-G. Zhan and D. Gao Catalytic Mechanism and Energy Barriers for Butyrylcholinesterase-Catalyzed Hydrolysis of Cocaine Biophys. J., December 1, 2005; 89(6): 3863 - 3872. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Pan, D. Gao, W. Yang, H. Cho, G. Yang, H.-H. Tai, and C.-G. Zhan Computational redesign of human butyrylcholinesterase for anticocaine medication PNAS, November 15, 2005; 102(46): 16656 - 16661. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Kreek, G. Bart, C. Lilly, K. S. Laforge, and D. A. Nielsen Pharmacogenetics and Human Molecular Genetics of Opiate and Cocaine Addictions and Their Treatments Pharmacol. Rev., March 1, 2005; 57(1): 1 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Platt, J. K. Rowlett, S. Izenwasser, and R. D. Spealman Opioid Partial Agonist Effects of 3-O-Methylnaltrexone in Rhesus Monkeys J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 1030 - 1039. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Laizure, T. Mandrell, N. M. Gades, and R. B. Parker Cocaethylene Metabolism and Interaction with Cocaine and Ethanol: Role of Carboxylesterases Drug Metab. Dispos., January 1, 2003; 31(1): 16 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Satoh, P. Taylor, W. F. Bosron, S. P. Sanghani, M. Hosokawa, and B. N. L. Du Current Progress on Esterases: From Molecular Structure to Function Drug Metab. Dispos., May 1, 2002; 30(5): 488 - 493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Platt, J. K. Rowlett, and R. D. Spealman Discriminative Stimulus Effects of Intravenous Heroin and Its Metabolites in Rhesus Monkeys: Opioid and Dopaminergic Mechanisms J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 760 - 767. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kudo, K. Umehara, M. Hosokawa, G. Miyamoto, K. Chiba, and T. Satoh Phenacetin Deacetylase Activity in Human Liver Microsomes: Distribution, Kinetics, and Chemical Inhibition and Stimulation J. Pharmacol. Exp. Ther., July 1, 2000; 294(1): 80 - 88. [Abstract] [Full Text]
|
|
|
|
|
|
X.-J. Zhao, E. Koyama, and T. Ishizaki An In Vitro Study on the Metabolism and Possible Drug Interactions of Rokitamycin, a Macrolide Antibiotic, Using Human Liver Microsomes Drug Metab. Dispos., July 1, 1999; 27(7): 776 - 785. [Abstract] [Full Text]
|
|
|
|
|
|
J. Zhang, J. C. Burnell, N. Dumaual, and W. F. Bosron Binding and Hydrolysis of Meperidine by Human Liver Carboxylesterase hCE-1 J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 314 - 318. [Abstract] [Full Text]
|
|
|
|
|
|
M. R. Brzezinski, B. J. Spink, R. A. Dean, C. E. Berkman, J. R. Cashman, and W. F. Bosron Human Liver Carboxylesterase hCE-1: Binding Specificity for Cocaine, Heroin, and their Metabolites and Analogs Drug Metab. Dispos., September 1, 1997; 25(9): 1089 - 1096. [Abstract] [Full Text]
|
|
|
|
 |
|
 E. V. Pindel, N. Y. Kedishvili, T. L. Abraham, M. R. Brzezinski, J. Zhang, R. A. Dean, and W. F. Bosron Purification and Cloning of a Broad Substrate Specificity Human Liver Carboxylesterase That Catalyzes the Hydrolysis of Cocaine and Heroin J. Biol. Chem., June 6, 1997; 272(23): 14769 - 14775. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
